|
Inhaltsverzeichnis |
Seite
|
Realität des Alkohol- und Drogenkonsumenten aus Sicht der Rechtsprechung: Die Unterbringung in der Entziehungsanstalt nach §64 StGB und die Zuru?ckstellung der Strafvollstreckung nach §35 BtMG – Allgemeine Grundlagen
Bernd Weidig |
215 |
LC-MS/MS of GHB in head hair and beard
Yvonne Hari, Stefan König, Alexandra Schröck, Patrizia Coro, Volker Auwärter, Annette Thierauf, Wolfgang Weinmann |
224 |
Comprehensive systematic toxicological analysis of human body fluids by parallel LC/MS/MS and GC/MS analysis
Florian Pitterl, Sebastian Köb, Johanna Pitterle, Birthe Schubert, Kathrin Libiseller, Herbert Oberacher |
228 |
Designerdrug 5-IT – a fatal case and analytical profiles of 5-IT and AMT
Jan Schäper, Folker Westphal, Susanna Fehn |
231 |
A fatal case involving several synthetic cannabinoids
Nadine Schaefer, Benjamin Peters, Dietmar Bregel, Stefan Kneisel, Volker Auwärter, Peter H. Schmidt, Andreas H. Ewald |
248 |
Postmortem blood and tissue concentrations of R- and S-enantiomers of methadone and its metabolite EDDP
Ricarda Jantos, Gisela Skopp |
252 |
Practical considerations for reliable quantification in postmortem specimens
Birgit Reiter, Kurt Jiran, Thomas Stimpfl |
260 |
A convenient method for Salvia divinorum analysis and attempt to explain different effects based on the origin
Victoria Spencer, Esra Ergin, Heike Wollersen, Nico Erdmann |
262 |
Can we obtain information from urine about recent cannabis consumption in DUID cases?
Sarah Hangartner, Franz Dussy, Thomas Briellmann |
266 |
Disaccharidnachweis im Urin: geeignete Markersubstanzen fu?r den intravenösen Substitutkonsum?
Hilke Jungen, Hilke Andresen- Streichert, Alexander Mueller, Stefanie Iwersen- Bergmann |
270 |
Combined analysis of synthetic cannabinoids and other designer drugs
Marek Dziadosz, Jens-Peter Weller, Michael Klintschar, Jörg Teske |
275 |
Fast, simple, and validated LC-HR-MS/MS assay for identification and quantification of drugs in human blood plasma often requested in context of brain death diagnosis
Markus R. Meyer, Andreas G. Helfer, Hans H. Maurer |
276 |
Methoxetamine: Metabolism and detectability of a novel ketamine analog – studied by GC-MS, LC-MSn, and LC-HR-MSn
Markus R. Meyer, Martina Bach, Michael Bovens, Alain Turcant, Hans H. Maurer |
277 |
Studies on the metabolism and detectability of the phenethylamine-derived designer drug 2C-P in rat and human urine using GC-MS, LC-MSn, and LC-HR-MS/MS
Markus R. Meyer, Tina Braun, Carina Wink, Alain Turcant, Hans H. Maurer |
278 |
Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine, and 3-methyl-amphetamine in rat urine using GC-MS, LC-MSn, and LC-HR-MSn
Jessica Welter, Markus R. Meyer, Pierce Kavanagh, Hans H. Maurer |
279 |
APAAN – a new precursor substance for the illicit production of amphetamine
Lars Müller, Nathalie Martin, Thorsten Rößler, Michael Pütz |
280 |
Forensic trace and comparative analysis related to clandestine amphetamine laboratories
Michael Pütz, Nathalie Martin, Nina Boxen, Jan Rittgen, Thorsten Rößler, Sabine Schneiders |
281 |
Development of an LC-MS/MS approach for screening and identification of benzodiazepines, z-drugs, antidepressants, neuroleptics, PDE-5 inhibitors, opioids and new synthetic drugs in human hair and urine samples
Deborah Montenarh, Markus Hopf, Stefan Warth, Hans H. Maurer, Peter Schmidt, Andreas H. Ewald |
282 |
Metabolism and toxicological detection of the new pyrrolidinophenone designer drug 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) in rat and human urine using GC-MS and LC-MSn
Markus R. Meyer, Sandra Mauer, Julia Dinger, Golo M. J. Meyer, Birgit Klein, Folker Westphal, Hans H. Maurer |
283 |
Determination of warfare agents (nerve agents, blister agents, saxitoxin and ricin) in food, water and on materials and articles
Martin Weber, Holger Schulz |
284 |
Verification of chemical warfare agent exposure in human samples
Paul W. Elsinghorst, Horst Thiermann, Marianne Koller |
288 |
Trapping 'Spice': a comprehensive, automated LC-ion trap-MS screening approach for the detection of currently 38 synthetic cannabinoids in serum
Laura M. Huppertz, Stefan Kneisel, Volker Auwärter, Jürgen Kempf |
293 |
Ein automatisiertes MSn-basiertes Screening Verfahren fu?r die klinische und forensische Toxikologie
Laura M. Huppertz, Susanne Vogt, Jürgen Kempf |
299 |
Extensive automation of the SPE-GC/MS analysis of opiates, cocaine, their metabolites and methadone from serum and other matrices
Oliver Temme, Oliver Lerch, Gernot Brauers, Thomas Daldrup |
304 |
N-Pentylindole: A marker for the detection of synthetic cannabinoids
Johannes Zagermann, Hellmut Mahler, Bauke H. Albada, Evelyn Pawlik |
308 |
Ethanol concentrations in breath and blood of drunk drivers; results from hand-held breathalyzer devices vs. analysis of venous blood samples
Pirkko Kriikku, Lars Wilhelm, Stefan Jenckel, Janne Rintatalo, Jukka Hurme, Jan Kramer |
312 |
Validation of an alcohol dehydrogenase method for forensic blood alcohol determination on Thermo Scientific Indiko analyzer and comparison with Technikon autoanalyzer
Marcel Grapp, Herbert Desel, Wolfgang Grellner |
315 |
Alternative determination of BAC by means of 1H-NMR
Bernd W. Diehl, Elina Zailer |
320 |
Quantification of the biogenic phenethylamine alkaloid hordenine by LC-MS/MS in beer
Gernot Brauers, Irina Steiner, Thomas Daldrup |
323 |
A preliminary investigation on the influence of flavonoids on ethyl glucuronide formation
Nicole Schwab, Gisela Skopp |
327 |
Analysis of morphine and codeine in dried blood on a carpet – a case report
Julia Krüger, Inge Herrle, Matthias Graw, Hans Sachs, Gabriele Roider |
332 |
Three unusual cases of CO poisoning with each two victims
Heike Wollersen, Freidoon Erdmann, Reinhard B. Dettmeyer, Kayleigh Hennemann, Victoria Spencer |
335 |
Abuse of pregabalin – results of the postmortem toxicology from 2010 to 2012
Stefanie Lottner-Nau, Birgit Övgu?er, Liane D. Paul, Matthias Graw, Hans Sachs, Gabriele Roider |
339 |
Fatality after intake of methylone, MDMA and amphetamine: a case report
Andreas Bauer, Jutta Schöpfer, Hans Sachs, Matthias Graw, Gabriele Roider |
343 |
Entdeckung zweier Leichname nach tödlicher Intoxikation durch orale Applikation von transdermalen Fentanylpflastern
Susanne Vogt, Volker Auwärter, Annette Thierauf |
346 |
Regular cannabis users in road traffic – a result of insufficient monitoring?!
Elke Below, Britta Bockholdt, Giovanni Talarico |
349 |
From palm to hair: transmissibility of methadone and its metabolite EDDP
Kerstin Boomgaarden-Brandes, Niels Tobias, John Koc, Hans Sachs, Bernd Mu?hlbauer |
354 |
Influence of hair straightening on ethyl glucuronide content in hair
Luc Kirchen, Michel Yegles |
357 |
Detection of illicit drugs in meconium to assess neonatal abstinence syndrome (NAS)
Volker Dangel, Rudolf Alkier, Manfred Möller |
359 |
LC/MS/MS method of 6-MAM, morphine, morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G) for quantitative analysis in serum
Susanne Lott, Frank Musshoff, Burkhard Madea |
363 |
Quality control charts for internal quality control of forensic blood alcohol analysis
Georg Schmitt, Gisela Skopp |
367 |
Auswertung von Ringversuchsdaten: Horwitz vs. DIN ISO 13528
Michael Herbold, Georg Schmitt, Gisela Skopp |
371 |
A pragmatic approach to detect SPICE metabolites in urine with HPLC-MS/MS
Lars Kröner, Victoria C. Spencer |
375 |
Studies on the metabolism and detectability of xylazine in rat and human urine using
Pharmacokinetics of GHB and detection window in serum and urine after single uptake of a low dose of GBL
Golo M.J. Meyer, Markus R. Meyer, Hans H. Maurer |
381 |
Pharmacokinetics of GHB and detection window in serum and urine after single uptake of a low dose of GBL
Alexandra Schröck, Yvonne Hari, Stefan König, Thomas Wu?thrich, Volker Auwärter, Annette Thierauf, Wolfgang Weinmann |
382 |
|
Autorenverzeichnis |
383 |
|
Sachwortverzeichnis |
385 |
